Details
Stereochemistry | ACHIRAL |
Molecular Formula | C4H2O4.Fe |
Molecular Weight | 169.901 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Fe++].[O-]C(=O)\C=C\C([O-])=O
InChI
InChIKey=PMVSDNDAUGGCCE-TYYBGVCCSA-L
InChI=1S/C4H4O4.Fe/c5-3(6)1-2-4(7)8;/h1-2H,(H,5,6)(H,7,8);/q;+2/p-2/b2-1+;
Molecular Formula | Fe |
Molecular Weight | 55.845 |
Charge | 2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C4H2O4 |
Molecular Weight | 114.0563 |
Charge | -2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
DescriptionSources: http://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfhttps://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502http://www.foodchemadditives.com/products/Ferrous-Lactatehttps://www.ncbi.nlm.nih.gov/pubmed/14116934DOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/3541174 | https://books.google.ru/books?id=7mxyBgAAQBAJ&pg=PA13&lpg=PA13&dq=%22ferrous+iodide%22+anemia&source=bl&ots=ZGyFhUiJZ4&sig=IZOhRVaGmlwX7GcqgoE6rnCsCa4&hl=ru&sa=X&ved=0ahUKEwjYu7PCyYHUAhWiQpoKHR6cCfcQ6AEIUjAJ#v=onepage&q=%22ferrous%20iodide%22&f=false
Sources: http://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfhttps://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502http://www.foodchemadditives.com/products/Ferrous-Lactatehttps://www.ncbi.nlm.nih.gov/pubmed/14116934DOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/3541174 | https://books.google.ru/books?id=7mxyBgAAQBAJ&pg=PA13&lpg=PA13&dq=%22ferrous+iodide%22+anemia&source=bl&ots=ZGyFhUiJZ4&sig=IZOhRVaGmlwX7GcqgoE6rnCsCa4&hl=ru&sa=X&ved=0ahUKEwjYu7PCyYHUAhWiQpoKHR6cCfcQ6AEIUjAJ#v=onepage&q=%22ferrous%20iodide%22&f=false
There is no information about biological and pharmacological application of Iron(II) fluoride (also known as ferrous fluoride). It is known, that this substance is used to catalyze some organic reactions.
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
|||
Primary | Ferro Sanol Duodenal Approved UseFerro Sanol is an iron substitute in case of latent or manifest iron deficiency with and without development of anaemia. |
|||
Curative | RADIOGARDASE Approved UseInsoluble Prussian blue is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium to increase their rates of elimination. Launch Date2003 |
|||
PubMed
Title | Date | PubMed |
---|---|---|
[FERROUS ASPARTATE IN THERAPY]. | 1964 Jan 1 |
|
Decreased treatment failure rates following duodenal release ferrous glycine sulfate in iron deficiency anemia associated with autoimmune gastritis and Helicobacter pylori gastritis. | 2007 |
|
The effect of iron treatment on adhesion molecules in patients with iron deficiency anemia. | 2010 Dec |
|
Tolerability of different oral iron supplements: a systematic review. | 2013 Apr |
|
A practical and successful desensitization protocol for immediate hypersensitivity reactions to iron salts. | 2014 |
Sample Use Guides
Adults should usually take one capsule a day. In cases of pronounced iron deficiency, adults can be given a dosage 2 to 3 times higher at the beginning of therapy. A daily dose of more than 5 mg Fe2+/kg body weight should in-well founded exceptional cases not be exceeded.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:56:02 GMT 2025
by
admin
on
Mon Mar 31 17:56:02 GMT 2025
|
Record UNII |
R5L488RY0Q
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
B03AD02
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
||
|
WHO-ATC |
B03AA02
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
||
|
CFR |
21 CFR 184.1307D
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
||
|
WHO-VATC |
QB03AA02
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
||
|
WHO-VATC |
QB03AD02
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
||
|
CFR |
21 CFR 172.350
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1200640
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
PRIMARY | |||
|
205-447-7
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
PRIMARY | |||
|
DB14491
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
PRIMARY | |||
|
141-01-5
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
PRIMARY | |||
|
24941
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
PRIMARY | |||
|
R5L488RY0Q
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
PRIMARY | |||
|
C61763
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
PRIMARY | |||
|
C031621
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
PRIMARY | |||
|
C1505
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
CONCEPT | Dietary Supplement | ||
|
FERROUS FUMARATE
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
PRIMARY | Description: A fine, reddish orange or reddish brown powder.Solubility: Slightly soluble in water; very slightly soluble in ethanol (~750 g/l) TS.Category: Iron supplement.Storage: Ferrous fumarate should be kept in a well-closed container.Definition: Ferrous fumarate contains not less than 93.0% and not more than 101.0% of C4H2FeO4, calculated with reference to the dried substance. | ||
|
486120
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
ALTERNATIVE | |||
|
m5343
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB13865MIG
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
PRIMARY | |||
|
R5L488RY0Q
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
PRIMARY | |||
|
DTXSID7047148
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
PRIMARY | |||
|
6433164
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
PRIMARY | |||
|
IRON(II) FUMARATE
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
PRIMARY | |||
|
100000090445
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
PRIMARY | |||
|
4261
Created by
admin on Mon Mar 31 17:56:02 GMT 2025 , Edited by admin on Mon Mar 31 17:56:02 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |